SCHEMBL7152177

SCHEMBL7152177

COc1ccccc1NS(=O)(=O)CCSc1nc2cc(C)ccc2s1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
HSD17B10 Q99714 1/20 0.46
MAPT P10636 11/20 0.43
LMNA P02545 4/20 0.43
HTT P42858 3/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
RXFP1 Q9HBX9 3/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 3/20 0.41
MEN1 O00255 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
GLA P06280 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7153019 0.94 MAPT (0.43) ALDH1A1HSD17B10MAPTLMNAHTT
SCHEMBL7146609 0.93 MAPT (0.42) ALDH1A1HSD17B10MAPTLMNAHTT
SCHEMBL7144785 0.90 MEN1 (0.42) ALDH1A1HSD17B10MAPTLMNAHTT
SCHEMBL7149622 0.89 ALDH1A1 (0.59) ALDH1A1HSD17B10MAPTLMNAHTT
SCHEMBL7144723 0.88 LMNA (0.49) ALDH1A1HSD17B10MAPTLMNAHTT
SCHEMBL7149130 0.84 MAPT (0.53) ALDH1A1HSD17B10MAPTLMNAHTT
SCHEMBL7153409 0.83 LMNA (0.48) ALDH1A1HSD17B10MAPTLMNAHTT
SCHEMBL7149158 0.83 KDM4E (0.48) ALDH1A1HSD17B10MAPTLMNAHTT
SCHEMBL7148781 0.83 ALDH1A1 (0.54) ALDH1A1HSD17B10MAPTLMNAHTT
SCHEMBL7149883 0.82 LMNA (0.53) ALDH1A1HSD17B10MAPTLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030176474-A1 Modulators of Rho C activity ICONIX BIOSCIENCES, INC. 2003-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176474-A1 Modulators of Rho C activity RHOC, ARHGDIA, ROCK1 ALDH1A1 2919/4885HSD17B10 2088/4885MAPT 3839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.